Amy Chandler
2021
In 2021, Amy Chandler earned a total compensation of $212.6K as Former Executive Vice President of Regulatory Affairs and Quality Management Systems at MARIZYME.
Compensation breakdown
| Option Awards | $10,823 |
|---|---|
| Salary | $201,826 |
| Total | $212,649 |
Chandler received $201.8K in salary, accounting for 95% of the total pay in 2021.
Chandler also received $10.8K in option awards.
Rankings
In 2021, Amy Chandler's compensation ranked 11,943rd out of 12,415 executives tracked by ExecPay. In other words, Chandler earned more than 3.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,943 out of 12,415 | 4th |
Division Manufacturing | 5,282 out of 5,508 | 4th |
Major group Chemicals And Allied Products | 2,303 out of 2,378 | 3rd |
Industry group Drugs | 2,042 out of 2,099 | 3rd |
Industry Pharmaceutical Preparations | 1,509 out of 1,549 | 3rd |
Source: SEC filing on November 10, 2022.
Chandler's colleagues
We found seven more compensation records of executives who worked with Amy Chandler at MARIZYME in 2021.
2021
Steven Brooks
MARIZYME
Chief Medical Officer
2021
Catherine Pachuk
MARIZYME
Chief Scientific Officer
2021
James Sapirstein
MARIZYME
Chief Executive Officer
2021
Neil Campbell
MARIZYME
Chief Executive Officer
2021
Roger Schaller
MARIZYME
former Executive Vice President of Commercial Operations
2021
David Barthel
MARIZYME
Chief Executive Officer
2021
Vithalbhai Dhaduk
MARIZYME